Genmab — September 2017
-
Hvad så med BCMA/CD38 bispecifik car-t, Solsen? https://www.clinicaltrials.gov/ct2/show/NCT03271632?term=bispecific+myeloma&rank=3
-
Bispecifik CD3/CD20 har været forsøgt før i MM. https://www.clinicaltrials.gov/ct2/show/NCT00938626?term=bispecific+myeloma&rank=2 Tilsyneladende uden at være kommet videre.
-
Det var jo oprindeligt det som gjorde Plesner betænkelig ved dara (cd38). Men det har jo siden vist sig at fungere udmærket. Måske er der som du siger en turboeffekt ved at molekylet med den ene arm griber fat i T-cellen og med den anden holder fast i cancercellen.
-
God morgen.

-
Præsentation på Genmab download side. Ikke umiddelbart noget nyt men ret omfattende: http://ir.genmab.com/downloads.cfm#tab1
-
Godmorgen fra Mallorca....i dejlig solskin
og 22 grader -
Q&A Zealand Pharma starter om få minutter.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind